Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biontech Se ADR
(NQ:
BNTX
)
96.86
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biontech Se ADR
< Previous
1
2
3
4
5
6
7
8
9
...
54
55
Next >
Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today?
November 21, 2023
Moderna Inc (NASDAQ: MRNA) shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent owned by Moderna is invalid, marking a victory for Pfizer Inc (NYSE: PFE) /
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology
November 15, 2023
Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CVAC), accusing it of failing to credit Acuitas on patents related to...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023
November 14, 2023
The global biotechnology market could nearly triple by 2030. Investors should consider buying these biotech stocks before they explode.
Via
InvestorPlace
Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
November 14, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page
Via
Benzinga
Analyst Ratings for BioNTech
November 14, 2023
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
Is BioNTech Stock a Buy Now?
October 25, 2023
Or is it too late to get in on the company after its coronavirus-related success?
Via
The Motley Fool
Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal
November 11, 2023
Eccogene, a Shanghai-Boston biotech, out-licensed global rights (ex-China) for its novel small molecule GLP-1 agonist to AstraZeneca in a $2 billion blockbuster deal. Eccogene will receive $185 million...
Via
Talk Markets
Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review
November 10, 2023
The major indexes ended long win streaks. Datadog led earnings winners.
Via
Investor's Business Daily
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
November 09, 2023
With questions rising about the economy, investors may consider undervalued biotech stocks for their relative insulation factor.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Mohamed El-Erian On Yield And Oil Price Drop: Economic Boon Or Major Downturn Ahead?
November 07, 2023
Via
Benzinga
BioNTech Se (BNTX) Q3 2023 Earnings Call Transcript
November 06, 2023
BNTX earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday
November 06, 2023
Eli Lilly jumped, while energy plays were big winners and losers.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside.
November 06, 2023
The company was expected to report a third-quarter loss and plummeting sales.
Via
Investor's Business Daily
Crude Oil Moves Higher; BioNTech Lowers 2023 Sales Outlook
November 06, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 40 points on Monday The Dow traded up 0.13% to 34,106.99 while the NASDAQ rose 0.16% to 13,499.42. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Like Moderna, BioNTech Cuts Annual Sales Forecast By 20% As Pandemic Fades
November 06, 2023
BioNTech SE (NASDAQ: BNTX) has reported Q3 revenues of €895.3 million ($974.49 million), sharply down from €3.461 billion a year ago.
Via
Benzinga
US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields
November 06, 2023
The market looks set to extend last week’s gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly from the small and mid-cap space.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
November 06, 2023
From
BioNTech SE
Via
GlobeNewswire
Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares
November 02, 2023
The company issued below-consensus sales views for 2023 and 2024.
Via
Investor's Business Daily
3 No-Brainer Stocks to Buy for Under $100 Right Now
October 28, 2023
A couple of these stocks might not be available for under $100 for too much longer.
Via
The Motley Fool
7 Undervalued Stocks That Analysts Love Right Now
October 26, 2023
With many investors concerned about what may lie ahead in the market, these potentially de-risked undervalued stocks may be ideal.
Via
InvestorPlace
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
October 26, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
October 26, 2023
From
BioNTech SE
Via
GlobeNewswire
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
October 23, 2023
From
BioNTech SE
Via
GlobeNewswire
Fighting the Silent Killer: Innovative Therapies for Pancreatic Cancer on the Rise
October 23, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(OTCQX:RHHBY),(NASDAQ:BNTX),(NASDAQ:ME) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023
October 23, 2023
From
BioNTech SE
Via
GlobeNewswire
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
The venerable pharmaceutical companies' shares have slumped this year.
Via
The Motley Fool
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
October 20, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
Pfizer Reportedly Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid
October 19, 2023
The transition to the commercial market is planned for 2024 and could bolster sales.
Via
Investor's Business Daily
7 Stocks That Are Heading for a Train Wreck
October 19, 2023
There's always a bear market somewhere. Here are seven stocks to sell that investors should definitely unload now.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.